Chemical Structure : TAK-385
CAS No.: 737789-87-6
Catalog No.: PC-20087Not For Human Use, Lab Use Only.
TAK-385 (Relugolix, TAK385) is a potent, orally active, non-peptide antagonist of human gonadotropin-releasing hormone (GnRH) receptor, inhibits GnRH-stimulated AA release from CHO cells expressing human GnRH receptor with IC50 of 0.85 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $88 | In stock | |
25 mg | $148 | In stock | |
50 mg | $248 | In stock | |
100 mg | $428 | In stock | |
250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
TAK-385 (Relugolix, TAK385) is a potent, orally active, non-peptide antagonist of human gonadotropin-releasing hormone (GnRH) receptor, inhibits GnRH-stimulated AA release from CHO cells expressing human GnRH receptor with IC50 of 0.85 nM.
TAK-385 exhibited strong binding affinity (IC50=0.32 nM) for monkey receptor comparable to that for the human receptor while displaying a 30000-fold decrease for the rat receptor (IC50=9800 nM).
TAK-385 displayed no significant activity in 134 different enzyme and radioligand binding assays.
TAK-385 showed potent in vitro GnRH antagonistic activity in the presence of fetal bovine serum (FBS) without CYP inhibition.
Oral administration of TAK-385 demonstrated the suppressive effect of the plasma luteinizing hormone levels in castrated cynomolgus monkeys at a 3 mg/kg dose for more than 24 h.
M.Wt | 623.64 | |
Formula | C29H27F2N7O5S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1-{4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea |
1. Miwa K, et al. J Med Chem. 2011 Jul 28;54(14):4998-5012.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright